A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants

Clinical trial NCT02427958 · COMPLETED

Trial details

NCT number: NCT02427958
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Central Precocious Puberty

Start date: 2015-08-07
Primary completion: 2018-11-23
Enrollment: 307

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.